Cargando…
Case report: apixaban‐induced thrombocytopenia
Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331230/ https://www.ncbi.nlm.nih.gov/pubmed/28265388 http://dx.doi.org/10.1002/ccr3.809 |